These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34061774)

  • 1. Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndrome.
    van Houten P; Netea-Maier R; Wagenmakers M; Roerink S; Hermus A; van de Ven A
    Eur J Endocrinol; 2021 Jul; 185(2):241-250. PubMed ID: 34061774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone loss is more severe in younger Cushing's syndrome women than in older ones: comparison of bone mineral density between Cushing's syndrome and healthy women].
    Jiang Y; Meng XW; Lu ZL; Xia WB; Xing XP; Li M; Wang O; Yu W; Tian JP
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1695-7. PubMed ID: 17825152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients.
    Apaydın T; Yavuz DG
    J Endocrinol Invest; 2021 Aug; 44(8):1767-1773. PubMed ID: 33420960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
    van der Eerden AW; den Heijer M; Oyen WJ; Hermus AR
    Neth J Med; 2007 Apr; 65(4):137-41. PubMed ID: 17452762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing's Syndrome.
    Stachowska B; Halupczok-Żyła J; Kuliczkowska-Płaksej J; Syrycka J; Bolanowski M
    Front Endocrinol (Lausanne); 2020; 11():593173. PubMed ID: 33584537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.
    Belaya ZE; Hans D; Rozhinskaya LY; Dragunova NV; Sasonova NI; Solodovnikov AG; Tsoriev TT; Dzeranova LK; Melnichenko GA; Dedov II
    Arch Osteoporos; 2015; 10():44. PubMed ID: 26608406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density and microarchitecture in endogenous hypercortisolism.
    dos Santos CV; Vieira Neto L; Madeira M; Alves Coelho MC; de Mendonça LM; Paranhos-Neto Fde P; Lima IC; Gadelha MR; Farias ML
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):468-74. PubMed ID: 25940452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study.
    Kristo C; Jemtland R; Ueland T; Godang K; Bollerslev J
    Eur J Endocrinol; 2006 Jan; 154(1):109-18. PubMed ID: 16381999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.
    Di Somma C; Pivonello R; Loche S; Faggiano A; Klain M; Salvatore M; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):302-8. PubMed ID: 12608935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome.
    Füto L; Toke J; Patócs A; Szappanos A; Varga I; Gláz E; Tulassay Z; Rácz K; Tóth M
    Osteoporos Int; 2008 Jul; 19(7):941-9. PubMed ID: 18043854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants.
    Trementino L; Appolloni G; Ceccoli L; Marcelli G; Concettoni C; Boscaro M; Arnaldi G
    Osteoporos Int; 2014 Mar; 25(3):913-21. PubMed ID: 24126765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
    Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
    Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.
    van Santen SS; Olsson DS; van den Heuvel-Eibrink MM; Wijnen M; Hammarstrand C; Janssen JAMJL; Johansson G; van der Lely AJ; Neggers SJCMM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1397-407. PubMed ID: 32145029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's syndrome and bone.
    Mancini T; Doga M; Mazziotti G; Giustina A
    Pituitary; 2004; 7(4):249-52. PubMed ID: 16010458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
    Di Somma C; Colao A; Pivonello R; Klain M; Faggiano A; Tripodi FS; Merola B; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 1998 May; 48(5):655-62. PubMed ID: 9666879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of bone mineral density after cure of Cushing's syndrome].
    Catargi B; Tabarin A; Basse-Cathalinat B; Ducassou D; Roger P
    Ann Endocrinol (Paris); 1996; 57(3):203-8. PubMed ID: 8949415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.